Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

Structural Determinants of the Neuronal Glycine Transporter 2 for the Selective Inhibitors ALX1393 and ORG25543

dc.contributor.authorBenito-Muñoz, Cristina
dc.contributor.authorPerona Requena, Almudena
dc.contributor.authorFelipe, Raquel
dc.contributor.authorPérez-Siles, Gonzalo
dc.contributor.authorNúñez, Enrique
dc.contributor.authorAragón, Carmen
dc.contributor.authorLópez-Corcuera, Beatriz
dc.date.accessioned2024-02-05T10:49:44Z
dc.date.available2024-02-05T10:49:44Z
dc.date.issued2021-05-18
dc.description.abstractThe neuronal glycine transporter GlyT2 modulates inhibitory glycinergic neurotransmission by controlling the extracellular concentration of synaptic glycine and the supply of neurotransmitter to the presynaptic terminal. Spinal cord glycinergic neurons present in the dorsal horn diminish their activity in pathological pain conditions and behave as gate keepers of the touch-pain circuitry. The pharmacological blockade of GlyT2 reduces the progression of the painful signal to rostral areas of the central nervous system by increasing glycine extracellular levels, so it has analgesic action. O-[(2-benzyloxyphenyl-3-fluorophenyl)methyl]-l-serine (ALX1393) and N-[[1-(dimethylamino)cyclopentyl]methyl]-3,5-dimethoxy-4-(phenylmethoxy)benzamide (ORG25543) are two selective GlyT2 inhibitors with nanomolar affinity for the transporter and analgesic effects in pain animal models, although with deficiencies which preclude further clinical development. In this report, we performed a comparative ligand docking of ALX1393 and ORG25543 on a validated GlyT2 structural model including all ligand sites constructed by homology with the crystallized dopamine transporter from Drosophila melanogaster. Molecular dynamics simulations and energy analysis of the complex and functional analysis of a series of point mutants permitted to determine the structural determinants of ALX1393 and ORG25543 discrimination by GlyT2. The ligands establish simultaneous contacts with residues present in transmembrane domains 1, 3, 6, and 8 and block the transporter in outward-facing conformation and hence inhibit glycine transport. In addition, differential interactions of ALX1393 with the cation bound at Na1 site and ORG25543 with TM10 define the differential sites of the inhibitors and explain some of their individual features. Structural information about the interactions with GlyT2 may provide useful tools for new drug discovery. © 2021 American Chemical Society.
dc.description.departmentDepto. de Química en Ciencias Farmacéuticas
dc.description.facultyFac. de Farmacia
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Economía y Competitividad (España)
dc.description.sponsorshipFundación Ramón Areces
dc.description.sponsorshipBanco Santader
dc.description.statuspub
dc.identifier.doi10.1021/acschemneuro.0c00602
dc.identifier.issn1948-7193
dc.identifier.officialurlhttps://doi.org/10.1021/acschemneuro.0c00602
dc.identifier.urihttps://hdl.handle.net/20.500.14352/98795
dc.issue.number111
dc.language.isoeng
dc.page.final1872
dc.page.initial1860
dc.publisherAmerican Chemical Society
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO/SAF2017-84235-R
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.cdu615:54
dc.subject.cdu615.31
dc.subject.keywordALX1393
dc.subject.keywordPain
dc.subject.keywordORG25543
dc.subject.keywordNeuronal glycine transporter 2
dc.subject.keywordInhibitor binding
dc.subject.keywordGlycinergic neurotransmission
dc.subject.ucmCiencias Biomédicas
dc.subject.ucmBiología molecular (Biología)
dc.subject.ucmFarmacia
dc.subject.ucmQuímica farmaceútica
dc.subject.unesco24 Ciencias de la Vida
dc.subject.unesco2490 Neurociencias
dc.titleStructural Determinants of the Neuronal Glycine Transporter 2 for the Selective Inhibitors ALX1393 and ORG25543
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number12
dspace.entity.typePublication
relation.isAuthorOfPublication6569fde4-f084-4c98-ab22-7797234df3c4
relation.isAuthorOfPublication.latestForDiscovery6569fde4-f084-4c98-ab22-7797234df3c4

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
benito-muñoz-et-al-2021-structural-determinants-of-the-neuronal-glycine-transporter-2-for-the-selective-inhibitors.pdf
Size:
3.69 MB
Format:
Adobe Portable Document Format

Collections